You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-FLT4 (FLT4) Antibodies

Full name:
anti-Fms-Related Tyrosine Kinase 4 Antibodies (FLT4)
On www.antibodies-online.com are 233 Fms-Related Tyrosine Kinase 4 (FLT4) Antibodies from 36 different suppliers available. Additionally we are shipping FLT4 Kits (41) and FLT4 Proteins (33) and many more products for this protein. A total of 315 FLT4 products are currently listed.
Synonyms:
6130401C07, AI323512, cb1059, Chy, Flk-1, Flk1, Flt-4, FLT41, Krd-1, LMPH1A, Ly73, PCL, sVEGFR-2, VEGFR-2, VEGFR-3, VEGFR2, Vegfr3

Most Popular Reactivities for anti-FLT4 (FLT4) Antibodies

Select your species and application

anti-Mouse (Murine) FLT4 Antibodies:

anti-Human FLT4 Antibodies:

anti-Rat (Rattus) FLT4 Antibodies:

All available anti-FLT4 Antibodies

Go to our pre-filtered search.

Top referenced anti-FLT4 Antibodies

  1. Human Monoclonal FLT4 Primary Antibody for WB - ABIN1882290 : Pajusola, Aprelikova, Korhonen, Kaipainen, Pertovaara, Alitalo, Alitalo: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. in Cancer research 1992 (PubMed)
    Show all 4 references for ABIN1882290

  2. Human Monoclonal FLT4 Primary Antibody for ELISA, WB - ABIN969147 : Goodyear, Kheyfets, Garcia, Stearns: Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines. in The Prostate 2009 (PubMed)
    Show all 3 references for ABIN969147

  3. Human Polyclonal FLT4 Primary Antibody for WB - ABIN616061 : Paone, Galli, Gabellini, Lukashev, Starace, Gorlach, De Cesaris, Ziparo, Del Bufalo, Sitkovsky, Filippini, Riccioli: Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. in Neoplasia (New York, N.Y.) 2010 (PubMed)
    Show all 3 references for ABIN616061

  4. Human Polyclonal FLT4 Primary Antibody for FACS, IF (p) - ABIN678578 : Wang, Zhou, Lin, Wang, Lin, Li: RhGH attenuates ischemia injury of intrahepatic bile ducts relating to liver transplantation. in The Journal of surgical research 2011 (PubMed)
    Show all 2 references for ABIN678578

  5. Human Polyclonal FLT4 Primary Antibody for IHC (fro), IHC (p) - ABIN115449 : Earnshaw, Halligan, Cooke, Heck, Liu: Topoisomerase II is a structural component of mitotic chromosome scaffolds. in The Journal of cell biology 1985 (PubMed)
    Show all 2 references for ABIN115449

  6. Human Monoclonal FLT4 Primary Antibody for EIA, IHC (fro) - ABIN115161 : Davids, Davids, Charlton, Ng, Chong, Laubscher, Dar, Hodge, Soong, Goh: Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 (PubMed)
    Show all 2 references for ABIN115161

  7. Human Monoclonal FLT4 Primary Antibody for EIA, WB - ABIN115160 : Jussila, Valtola, Partanen, Salven, Heikkilä, Matikainen, Renkonen, Kaipainen, Detmar, Tschachler, Alitalo, Alitalo: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. in Cancer research 1998 (PubMed)
    Show all 2 references for ABIN115160

  8. Mouse (Murine) Polyclonal FLT4 Primary Antibody for FACS - ABIN4896915 : Imoukhuede, Popel: Expression of VEGF receptors on endothelial cells in mouse skeletal muscle. in PLoS ONE 2012 (PubMed)

  9. Human Polyclonal FLT4 Primary Antibody for IHC (p) - ABIN115450 : Dietrich, Onderka, Bock, Kruse, Vossmeyer, Stragies, Zahn, Cursiefen: Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. in The American journal of pathology 2007 (PubMed)

More Antibodies against FLT4 Interaction Partners

Mouse (Murine) Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. Introduction of sVEGFR-2 suppressed lymphangiogenesis in primary lung cancer and also suppressed lymphogenic metastasis by inhibiting VEGF-C (show VEGFC Antibodies), followed by down-regulation of VEGFR-2 (show KDR Antibodies), VEGFR-3 and MMPs.

  2. VEGFB (show VEGFB Antibodies)-Induced Vascular Remodeling in Adipose Tissue Requires VEGF (show VEGFA Antibodies)/VEGFR2 (show KDR Antibodies). VEGFB (show VEGFB Antibodies)-Induced Vascular Remodeling Improves Insulin (show INS Antibodies) Supply, Signaling, and Function in Obese Mice.

  3. demonstrated that Id1 (show ID1 Antibodies) and E2-2 (show TCF4 Antibodies) are critical regulators of EPCs function in vitro. Id1 (show ID1 Antibodies) interacts with E2-2 (show TCF4 Antibodies) and relieves the E2-2 (show TCF4 Antibodies)-mediated repression of FGFR1 (show FGFR1 Antibodies) and VEGFR2 (show KDR Antibodies) expression to modulate EPCs functions

  4. Data suggest that expression of Notch-1 (show NOTCH1 Antibodies) receptor in endothelial progenitor cells (EPC (show TCF21 Antibodies)) in bone marrow is up-regulated in diabetic angiopathy (DA); signaling in EPC (show TCF21 Antibodies) via Notch-1 (show NOTCH1 Antibodies) receptor and VEGFA (show VEGFA Antibodies)/VEGFR2 (show KDR Antibodies) appears to be altered in DA.

  5. Collectively, these data suggest that VEGF (show VEGFA Antibodies)/VEGFR2 (show KDR Antibodies) signaling regulates germ cell proliferation and promotes testicular regeneration via direct action on germ cells and the enhancement of vascularization.

  6. this study uncovers a unique molecular mechanism of lymphangiogenesis in which galectin-8 (show LGALS8 Antibodies)-dependent crosstalk among VEGF-C (show VEGFC Antibodies), podoplanin (show PDPN Antibodies) and integrin pathways plays a key role.

  7. administration of 0.3 IU/mL FSH (show BRD2 Antibodies) during ovarian cryopreservation by vitrification can maintain ovarian survival during ovarian vitrification and increases the blood supply with avascular transplantation via upregulation of Cx43 (show GJA1 Antibodies), Cx37 (show GJA4 Antibodies), and VEGF (show VEGFA Antibodies)/VEGFR2 (show KDR Antibodies)

  8. The data provide new insights for the chaperone function of PDCL3 (show PDCL3 Antibodies) in angiogenesis and the roles of hypoxia and N-terminal methionine acetylation in PDCL3 (show PDCL3 Antibodies) expression and its effect on VEGFR-2 (show KDR Antibodies).

  9. VEGFA (show VEGFA Antibodies)-induced vascular leakage depends on signaling initiated via the VEGFR2 (show KDR Antibodies) phosphosite Y949. Abolished Y949 signaling in the mutant Vegfr2 (show KDR Antibodies)(Y949F/Y949F) leads to VEGFA (show VEGFA Antibodies)-resistant endothelial adherens junctions.

  10. These findings together demonstrate the essential role of KDM4A (show KDM4A Antibodies) and KDM4C (show KDM4C Antibodies) in orchestrating mESC differentiation to endothelial cells through the activation of Flk1 (show KDR Antibodies) and VE-cadherin (show CDH5 Antibodies) promoters, respectively

Human Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. This study suggests that NRP1 (show NELL1 Antibodies) expression and LVD are independent factors that are likely to predict the risk of LN metastasis in squamous cell carcinoma (SCC (show CYP11A1 Antibodies))of the tongue, whereas the expression of VEGFC (show VEGFC Antibodies), VEGFR3, CCR7 (show CCR7 Antibodies), and SEMA3E (show SEMA3E Antibodies) are nonindependent predictive factors

  2. Data indicate that vascular endothelial growth factor D (VEGF-D (show Figf Antibodies)) was the best indicator of metastasis and vascular endothelial growth factors and receptor-3 (VEGFR-3) may help to determine the prognosis and management of colorectal cancer (CRC (show CALR Antibodies)).

  3. The summarizes the structure and function features of pathway-related molecules of VEGFC (show VEGFC Antibodies)/D-VEGFR3/NRP2 (show NELL2 Antibodies) axis, stages of various tumors and their molecular mechanisms and significances in tuthe expression changes of these molecules in different anatomic organs or histopathologic types or development lymphatic metastasis.

  4. The most extensively accepted signaling pathways promoting lymphangiogenesis in tumors include the secreted lymphangiogenic proteins: VEGF-C (show VEGFC Antibodies) and VEGF-D (show Figf Antibodies), and their cognate receptor on lymphatic endothelium VEGF receptor (show FLT1 Antibodies)-3 (VEGFR-3).

  5. MTA1 (show MTA1 Antibodies) is up-regulated in CRC (show CALR Antibodies); its expression is inversely associated with lymphatic metastases and the expression of VEGFC (show VEGFC Antibodies), VEGFD (show Figf Antibodies) and VEGFR3

  6. this study uncovers a unique molecular mechanism of lymphangiogenesis in which galectin-8 (show LGALS8 Antibodies)-dependent crosstalk among VEGF-C (show VEGFC Antibodies), podoplanin (show PDPN Antibodies) and integrin pathways plays a key role.

  7. Report FLT4 genetic alterations in angiosarcomas.

  8. High expression levels of VEGFR1 (show FLT1 Antibodies) and VEGFR3 were associated with a higher rate of lung metastasis.

  9. Data indicate that foretinib suppresses angiogenesis and lymphangiogenesis by blocking vascular endothelial growth factor receptors

  10. Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis.

Zebrafish Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. Ca(2 (show CA2 Antibodies)+) oscillations depended upon VEGF receptor-2 (Vegfr2) and Vegfr3 in endothelial cells budding from the dorsal aorta (DA) and posterior cardinal (show CARD8 Antibodies) vein, respectively.

  2. Experiments in mice and zebrafish demonstrate that changing levels of VEGFR3/Flt4 modulates aortic lumen diameter consistent with flow-dependent remodeling

  3. In the embryo, phenotypes driven by increased Vegfc (show VEGFC Antibodies) are suppressed in the absence of Ccbe1 (show CCBE1 Antibodies), and Vegfc (show VEGFC Antibodies)-driven sprouting is enhanced by local Ccbe1 (show CCBE1 Antibodies) overexpression. Moreover, Vegfc (show VEGFC Antibodies)- and Vegfr3-dependent Erk (show MAPK1 Antibodies) signaling is impaired in the absence of Ccbe1 (show CCBE1 Antibodies).

  4. Flt4 plays an essential role in lymphangiogenesis [review]

  5. The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc (show VEGFC Antibodies)/Vegfr3 signaling in zebrafish.

  6. Rspo1-Wnt-VegfC-Vegfr3 signaling plays a crucial role as an endothelial-autonomous permissive cue for developmental angiogenesis.

  7. flt4 signalling is suppressed by Dll4 (show DLL4 Antibodies) in developing zebrafish intersegmental arteries.

FLT4 Antigen Profile

Antigen Summary

This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.

Alternative names and synonyms associated with FLT4

  • FMS-like tyrosine kinase 4 (Flt4) antibody
  • fms-related tyrosine kinase 4 (FLT4) antibody
  • fms-related tyrosine kinase 4 (Flt4) antibody
  • fms-related tyrosine kinase 4 (flt4) antibody
  • kinase insert domain protein receptor (Kdr) antibody
  • 6130401C07 antibody
  • AI323512 antibody
  • cb1059 antibody
  • Chy antibody
  • Flk-1 antibody
  • Flk1 antibody
  • Flt-4 antibody
  • FLT41 antibody
  • Krd-1 antibody
  • LMPH1A antibody
  • Ly73 antibody
  • PCL antibody
  • sVEGFR-2 antibody
  • VEGFR-2 antibody
  • VEGFR-3 antibody
  • VEGFR2 antibody
  • Vegfr3 antibody

Protein level used designations for FLT4

chylous ascites , receptor protein tyrosine kinase , tyrosine-protein kinase receptor FLT4 , vascular endothelial growth factor receptor 3 , vascular endothelial growth factor receptor-3 , FLT-4 , VEGFR-3 , fms-like tyrosine kinase 4 , soluble VEGFR3 variant 1 , soluble VEGFR3 variant 2 , soluble VEGFR3 variant 3 , FMS-like tyrosine kinase 4 , tyrosine kinase VEGFR-3 , VEGFR3 , expando , receptor tyrosine kinase Flt4 , VEGF receptor-2 , fetal liver kinase 1 , kinase NYK , protein-tyrosine kinase receptor flk-1 , soluble vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor- 2 , vascular endothelial growth factor receptor-2

GENE ID SPECIES
14257 Mus musculus
2324 Homo sapiens
114110 Rattus norvegicus
338031 Bos taurus
100008829 Oryctolagus cuniculus
395742 Gallus gallus
30121 Danio rerio
16542 Mus musculus
Selected quality suppliers for anti-FLT4 (FLT4) Antibodies
Did you look for something else?